Agilent Technologies (A) Shares are Down -0.68%

Agilent Technologies (A) : During the past 4 weeks, traders have been relatively bearish on Agilent Technologies (A), hence the stock is down -0.9% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -1.17% relative to the S&P 500. The 4-week change in the price of the stock is -1.03% and the stock has fallen -0.68% in the past 1 week.

The stock has recorded a 20-day Moving Average of 1.14% and the 50-Day Moving Average is 0.94%.The 200 Day SMA reached 12.12%. Agilent Technologies, Inc. is up 2.76% in the last 3-month period. Year-to-Date the stock performance stands at 13.04%.


Agilent Technologies (NYSE:A): After opening at $47.23, the stock dipped to an intraday low of $46.89 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $47.39 and the buying power remained strong till the end. The stock closed at $47 for the day, a gain of 0.02% for the day session. The total traded volume was 1,424,454. The stocks close on the previous trading day was $46.99.

Agilent Technologies Inc. is engaged in the life sciences, diagnostics and applied chemical markets. The Company provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company has three business segments: the life sciences and applied markets business, the diagnostics and genomics business, and the Agilent CrossLab business. The Companys life sciences and applied markets business segment brings together the Companys analytical laboratory instrumentation and informatics. The Companys diagnostics and genomics business segment consists of three businesses: the Dako business, the genomics business and the nucleic acid solutions business. The Companys Agilent CrossLab business segment combines its analytical laboratory services and consumables business.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.